Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Other Non-Current Liabilities (2024 - 2026)

Carlsmed filings provide 2 years of Other Non-Current Liabilities readings, the most recent being $309000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 32.39% to $309000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $309000.0, a 32.39% decrease, with the full-year FY2025 number at $309000.0, down 32.39% from a year prior.
  • Other Non-Current Liabilities hit $309000.0 in Q4 2025 for Carlsmed, up from $32000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $727000.0 in Q2 2025 to a low of $32000.0 in Q3 2025.